Jaguar Health, Inc. (NASDAQ:JAGX) | WebDisclosure

Basculer en Français

9475	Companies
185451	Keywords
117789	Articles
99301	Press releases

Home
Companies
Jaguar Health, Inc.

PRESS RELEASE

published on 11/06/2025 at 15:00, 28 days 21 hours ago

REMINDER: Initial Groundbreaking Results of Proof-of-Concept Study of Jaguar Health's Crofelemer for Treatment of Pediatric Intestinal Failure to be Presented November 8, 2025 at North American Society for Pediatric Gastroenterology, Hepatology and Nutrit
Ongoing trial of crofelemer in UAE shows reduction in parenteral support for pediatric intestinal failure patients. Breakthrough in MVID and SBS-IF treatment

Crofelemer MVID SBS-IF Intestinal Failure UAE Trial
BRIEF

published on 10/24/2025 at 22:20, 1 month 11 days ago

Jaguar Health annonce des subventions incitatives conformément à la réglementation du Nasdaq

Jaguar Health RSU Médicaments Règle Du Nasdaq Incitation Des Employés
BRIEF

published on 10/24/2025 at 22:20, 1 month 11 days ago

Jaguar Health Announces Inducement Grants Under Nasdaq Rule

Pharmaceuticals Jaguar Health RSUs Nasdaq Rule Employee Inducement
PRESS RELEASE

published on 10/24/2025 at 22:15, 1 month 11 days ago

Jaguar Health Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Jaguar Health, Inc. (NASDAQ:JAGX) granted RSUs to new employees effective October 20, 2025. RSUs vest over one year. The Company focuses on developing prescription medicines from rainforest plants for gastrointestinal distress

Gastrointestinal Distress Jaguar Health RSUs New Employees Prescription Medicines
BRIEF

published on 10/06/2025 at 15:05, 1 month 29 days ago

Jaguar Health fait progresser le développement du Crofelemer pour le traitement de la MVID lors d'une réunion de la FDA

Crofelemer Jaguar Health MVID Réunion De La FDA Procès Aux Émirats Arabes Unis
BRIEF

published on 10/06/2025 at 15:05, 1 month 29 days ago

Jaguar Health Advances Development with FDA Meeting on Crofelemer for MVID Treatment

Crofelemer Jaguar Health MVID FDA Meeting UAE Trial
PRESS RELEASE

published on 10/06/2025 at 15:00, 1 month 29 days ago

Jaguar Health Completes Meeting with FDA for Advice on Development Pathways to Advance Ongoing Crofelemer Trial for Potential Approval for Treatment of Pediatric Indication Microvillus Inclusion Disease (MVID)
Napo Pharmaceuticals provides update on ongoing clinical trial for the treatment of MVID in pediatric patients, showing significant reduction in parenteral support in UAE. FDA advice sought for study advancement

FDA Napo Pharmaceuticals Clinical Trial Pediatric Patients MVID
BRIEF

published on 09/30/2025 at 15:05, 2 months 4 days ago

Jaguar Health fournit Crofelemer pour le traitement de l'insuffisance intestinale pédiatrique

Crofelemer Jaguar Health Maladie D'inclusion Microvillositaire Traitement Pédiatrique Programmes De La FDA
BRIEF

published on 09/30/2025 at 15:05, 2 months 4 days ago

Jaguar Health Provides Crofelemer for Pediatric Intestinal Failure Treatment

Crofelemer Microvillus Inclusion Disease Jaguar Health Pediatric Treatment FDA Programs
PRESS RELEASE

published on 09/30/2025 at 15:00, 2 months 4 days ago

FDA-Authorized Expanded Access Programs Utilizing Jaguar Health's Novel Crofelemer Powder for Oral Solution to Treat Two Pediatric Intestinal Failure Patients with Microvillus Inclusion Disease
Jaguar Health announces expanded access programs for pediatric patients with microvillus inclusion disease using crofelemer powder. Positive results from initial trials presented

Microvillus Inclusion Disease Jaguar Health Pediatric Patients Crofelemer Powder Expanded Access Programs

Accesswire

Published on 12/05/2025 at 02:35, 10 hours 22 minutes ago

Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 02:30, 10 hours 27 minutes ago

Klondike Gold Announces AGM Results
Published on 12/05/2025 at 01:00, 11 hours 57 minutes ago

BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 13 hours 52 minutes ago

BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 13 hours 57 minutes ago

NXT Energy Solutions Completes Data Acquisition for SFD Survey

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 12:05, 52 minutes ago

Cango Inc. Announces November 2025 Bitcoin Production and Mining Operations Update
Published on 12/05/2025 at 12:00, 57 minutes ago

CGTN：Strengthening cultural ties: Peng Liyuan, Brigitte Macron visit Beijing People's Art Theatre
Published on 12/05/2025 at 12:00, 57 minutes ago

Iute Group: Successful Issue of Additional EUR 2025/2030 Bonds – Circulating Volume Increased to EUR 160 Million
Published on 12/05/2025 at 11:14, 1 hour 43 minutes ago

Halfords Group PLC: Director/PDMR Shareholding
Published on 12/05/2025 at 11:08, 1 hour 48 minutes ago

Linedata Services: Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social

Les Echos

Published on 12/05/2025 at 08:45, 4 hours 12 minutes ago

Air Liquide va étendre et électrifier son unité de production d'oxygène à Shaanxi, soutenant ainsi l'engagement de la Chine à décarboner son industrie
Published on 12/05/2025 at 08:45, 4 hours 12 minutes ago

Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry
Published on 12/05/2025 at 08:42, 4 hours 15 minutes ago

ENGIE - déclaration mensuelle du nombre total d'actions et de droits de vote composant le capital au 30 novembre 2025
Published on 12/04/2025 at 18:14, 18 hours 42 minutes ago

Résiliation d'une convention conclue entre actionnaires
Published on 12/04/2025 at 18:00, 18 hours 57 minutes ago

Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 28 novembre 2025

View all LES ECHOS COMFI WIRE